LONDON MARKETS: FTSE 100 Slips, But Miners Find Relief After Selloff
26 August 2016 - 10:31AM
Dow Jones News
By Carla Mozee, MarketWatch
Investors wait to hear from Fed chief Yellen
U.K. stocks ebbed lower Friday, set to round off the week with a
loss, as investors waited for an update on U.K. economic growth and
a closely watched speech from U.S. Federal Reserve Chairwoman Janet
Yellen.
The FTSE 100 was down 0.2% at 6,802.00, with health care and
consumer goods among the declining sectors. Miners were higher
after being under pressure this week. The London benchmark was on
track to fall 0.6% for the week, which would be a second straight
weekly loss.
The index on Thursday lost 0.3%
(http://www.marketwatch.com/story/ftse-100-struggles-as-miners-drug-makers-pull-lower-2016-08-25),
weighed by those losses for miners and for drug makers.
But on Friday, BAE Systems PLC (BA.LN) topped the FTSE 100.
Shares rose 1.2% as the defense company's rating was upgraded to
buy from hold at Berenberg.
"We anticipate a material order book uplift, an improving cash
profile in 2017 (with potential upside to guidance), and a secure
progressive dividend across our forecast," wrote Berenberg analyst
Charlotte Keyworth in a research note.
Economic docket: Friday's session will see the release of a
second reading of Britain's gross domestic product for the second
quarter. A confirmation of the preliminary print of 0.6% is
expected.
Later in the day, investors will watch for hints on the future
of U.S. interest rates from Yellen, who will address attendees at
the central bank's summer summit in Jackson Hole, Wyo. She's slated
to speak at 3 p.m. London time, or 10 a.m. Eastern Time.
Read:The 4 scenarios investors face ahead of Yellen's Jackson
Hole speech
(http://www.marketwatch.com/story/the-4-scenarios-investors-face-ahead-of-yellens-jackson-hole-speech-2016-08-25)
Ahead of the U.K. GDP release, the pound fetched $1.3217, up
from $1.3175 late Thursday in New York.
Movers: Shares of Glencore PLC (GLEN.LN) rose 0.9% after two
sessions of heavy declines, after the miner posted a half-year loss
of $369 million
(http://www.marketwatch.com/story/glencore-steps-up-debt-cuts-as-it-swings-to-loss-2016-08-24).
Other mining stocks rose as well, with Rio Tinto PLC (RIO) (RIO)
(RIO) up 1.4% and Antofagasta PLC (ANTO.LN) higher by 1.2%.
But drug makers remained under pressure in the wake of backlash
about drug pricing in the U.S. The furor was spurred by a
substantial price hike for Mylan NV's (MYL) EpiPen, an emergency
allergy treatment.
Read:How Hillary Clinton crushed another rally in biotech
(http://www.marketwatch.com/story/how-hillary-clinton-crushed-another-rally-in-biotech-2016-08-24)
In London, Shire PLC (SHPG) (SHPG) fell 1.6%, AstraZeneca PLC
(AZN.LN) (AZN.LN) was down 1%, and GlaxoSmithKline PLC
(GSK.LN)(GSK.LN) lost 0.7%.
Hikma Pharmaceuticals PLC (HIK.LN) , however, picked up
0.4%.
(END) Dow Jones Newswires
August 26, 2016 04:16 ET (08:16 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
FTSE 100
Index Chart
Von Feb 2024 bis Mär 2024
FTSE 100
Index Chart
Von Mär 2023 bis Mär 2024